|
Match
|
Document |
Document Title |
|
|
7629340 |
N-(6-membered aromatic ring)-amido anti-viral compounds
Disclosed are compounds having Formula (I) and the compositions and methods relating to these compounds, for treating or preventing a viral infection mediated at least in part by a virus in the...
|
|
|
7625934 |
Metalloproteinase inhibitors
Compounds of the formula (I) wherein z is SO 2 or SO, useful as metalloproteinase inhibitors, especially as inhibitors of MMP12.
|
|
|
7622491 |
Modulators of PPAR and methods of their preparation
The present invention is directed to certain novel compounds represented by Formula (I) and pharmaceutically acceptable salts, solvates, hydrates and prodrugs thereof. The present invention is also...
|
|
|
7618993 |
Compounds
The present invention relates to new compounds
or salts, solvates or solvated salts thereof, processes for their preparation and to new intermediates used in the preparation thereof,...
|
|
|
7589115 |
Derivatives of [6,7-dihydro-5H-imidazo[1,2-α]imidazole-3-sulfonylamino]-propionamide
Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-pro
pionamide which exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the...
|
|
|
7582770 |
Viral polymerase inhibitors
An enantiomer, diastereoisomer or tautomer of a compound, represented by formula I:
wherein A, B, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , and R 10 are as defined herein, or a...
|
|
|
7579389 |
Antimicrobial acrylic polymer
An antimicrobial additive composition is provided which economically and efficiently imparts antimicrobial characteristics to acrylic polymers, and particularly thermoformable acrylic sheets made...
|
|
|
7579368 |
Cis-imidazolines
There are presented compounds of the formula
or pharmaceutically acceptable salts thereof,
wherein Y 1 , Y 2 , X 1 , X 2 , X 3 and R are as described in this application. These compounds are...
|
|
|
7576114 |
N3 alkylated benzimidazole derivatives as MEK inhibitors
Disclosed are compounds of the Formula I
and pharmaceutically acceptable salts and prodrugs thereof, wherein W, R 1 , R 2 , R 7 , R 8 , R 9 and R 10 are as defined in the specification. Such...
|
|
|
7572816 |
Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
The present invention is directed to compounds having the structure wherein R 1 , R 2 , R 3 , R 4 , R 5 and m are as defined herein. The compounds of this invention are novel therapeutic agents...
|
|
|
7569595 |
2-((2-thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronaphthalen-1(2H)-one
A compound of the formula
or a pharmaceutically acceptable salt thereof, is disclosed herein. Methods and compositions related thereto are also disclosed.
|
|
|
7563814 |
Olmesartan medoxomil with reduced levels of impurities
The present invention provides the preparation of olmesartan medoxomil containing less than about 0.1% of one or more of the impurities OLM-Me, OLM-Cl, and OLM-eliminate.
|
|
|
7557136 |
Pyrrolidine derivatives as oxytocin antagonists
The present invention relates to novel pyrrolidine derivatives of Formula (I), its geometrical isomers, its optically active forms as enantiomers, diastercomers, mixtures of these and its racemate...
|
|
|
7547718 |
Substituted imidazoles
This invention relates to a range of alpha substituted 2-benzyl substituted imidazole compounds and pharmaceutically acceptable salts and solvates thereof, to compositions comprising such...
|
|
|
7544705 |
Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents
Described herein are new bicyclic arylimidazolones having nootropic action (i.e., protecting and stimulating cerebral functions), analgesic action and anti hyperalgesic action; also described is...
|
|
|
7541375 |
Azole derivatives and pharmaceutical compositions containing them
The invention provides substituted pyrazolidinone compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention...
|
|
|
7531560 |
Anti-cytokine heterocyclic compounds
Disclosed are compounds of formula (I)
which inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving...
|
|
|
7524875 |
Modified bio-related substance, process for producing the same, and intermediate
A modified bio-related substance, wherein at least one poly(alkylene glycol)oxy group represented by the following formula (1) is combined in a molecule:
wherein R is a hydrocarbon group having...
|
|
|
7524867 |
Tetrasubstituted imidazole derivatives as cannabinoid CB1 receptor modulators with a high CB1/CB2 receptor subtype selectivity
The present invention relates to 1,2,4,5-tetrasubstituted imidazole derivatives as selective cannabinoid CB 1 receptor modulators, in particular CB 1 receptor antagonists or inverse agonists...
|
|
|
7521470 |
Factor Xa inhibitors
The present invention is directed to compounds represented by Formula I and pharmaceutically acceptable salts, solvates, hydrates, and prodrugs thereof which are inhibitors of Factor Xa. The...
|
|
|
7514459 |
Gamma-secretase inhibitors
Compounds of formula I:
are potent inhibitors of gamma-secretase and hence find use in treatment or prevention of diseases associated with deposition of β-amyloid.
|
|
|
7511068 |
Mercaptoimidazoles as CCR2 receptor antagonists
The present invention relates to a compound of formula (I) having CCR2 receptor antagonistic properties, particularly anti-inflammatory properties.
|
|
|
7511067 |
3-hydroxymethyl-4-hydroxy-phenyl-derivatives for the treatment of respiratory diseases
The present invention relates to the use of the compounds of general formula 1
wherein the groups R 1 , X and Y may have the meanings given in the claims and in the specification, for preparing...
|
|
|
7507755 |
Inhibitors of cathepsin s
The present invention provides compounds, compositions and methods for the selective inhibition of cathepsin S. In a preferred aspect, cathepsin S is selectively inhibited in the presence of at...
|
|
|
7507756 |
Scalable synthesis of imidazole derivatives
Imidazole derivatives, compositions containing them, methods of preparing them, including regioselective scale-up synthetic methods, and methods of using them.
|
|
|
7504425 |
Compounds useful in the treatment of anthrax and inhibiting lethal factor
This invention relates to compounds of formula (I), and a method for treating anthrax or inhibiting lethal factor by administrating a composition containing a compound of formula (I) and a...
|
|
|
7501447 |
Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
Compounds of formula (I) or pharmaceutically acceptable salts thereof: wherein R1, R2, R3, R4 and Z are as defined in the specification as well as salts and pharmaceutical compositions including...
|
|
|
7501448 |
Process for preparing telmisartan
Provided are processes for preparing telmisartan alkyl ester and telmisartan using environmentally friendly organic solvents that are easily removed from the reaction mixture, wherein a telmisartan...
|
|
|
7498354 |
Pyrrolo[2,3-D]imidazoles for the treatment of hyperproliferative disorders
or a pharmaceutically acceptable salt or N-oxide thereof, are useful in the treatment of tumors and cancers.
|
|
|
7470716 |
Imidazoles and triazoles, their preparation, and their use as pharmaceutical compositions
The present invention relates to imidazoles and triazoles of general formula
wherein R 1 to R 4 and X are defined as in claims 1 to 8, the tautomers, the enantiomers, the diastereomers, the...
|
|
|
7465811 |
Indoline compounds
Sulfonylindoline compounds of formula I,
wherein R1 through R4, Y and Z have defined meanings, a process for preparation of such compounds, and the use as pharmaceutically active substances,...
|
|
|
7456204 |
Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
The present invention is directed to novel cyclohexylglycine derivatives which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DP-IV inhibitors”) and which are useful in the treatment or...
|
|
|
7449195 |
Fungicide mixtures
Fungicidal mixtures, comprising
A) imidazole derivatives of the formula I
in which R 1 and R 2 are halogen or phenyl, which may be substituted by halogen or alkyl, or R 1...
|
|
|
7442716 |
2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors
The invention encompasses novel compounds of Formula I
or pharmaceutically acceptable salts thereof. These compounds are inhibitors of the microsomal prostaglandin E synthase-1 (mPGES-1) enzyme...
|
|
|
7427631 |
Metalloproteinase inhibitors
Compounds of the formula (I) wherein z is SO 2 or SO, useful as metalloproteinase inhibitors, especially as inhibitors of MMP12.
|
|
|
7419995 |
N-substituted benzimidazoyl c-Kit inhibitors and combinatorial benzimidazole library
Compounds represented by Formula (I):
or a pharmaceutically acceptable salt or N-oxide thereof, are useful in the treatment of tumors. Combinatorial libraries composed of compounds represented...
|
|
|
7417030 |
Indazole peptidomimetics as thrombin receptor antagonists
The invention is directed to novel indazole peptidomimetic compounds which are useful as thrombin receptor antagonists for the treatment of diseases associated with thrombosis, restenosis,...
|
|
|
7390506 |
Lipophilic drug compositions
The invention is directed to biologically active lipophilic compositions comprising a biologically active covalently attached to, or encapsulated within, a lipid. Preferably, a biologically active...
|
|
|
7390824 |
Method for treating diabetes employing an aP2 inhibitor and combination
A method is provided for treating diabetes and related diseases, especially Type II diabetes, employing an aP2 inhibitor or a combination of an aP2 inhibitor and another antidiabetic agent such as...
|
|
|
7390829 |
Alpha-2 adrenergic agonists
A compound is disclosed herein comprising
or a pharmaceutically acceptable salt or a prodrug thereof;
wherein R is OH or NH 2 .
Methods, compositions, and medicaments related thereto are...
|
|
|
7368467 |
Ion channel modulators
The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein...
|
|
|
7361663 |
N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa
This invention is directed to N-acylpyrrolidin-2-ylalkylbenzamidine derivatives which useful for inhibiting the activity of Factor Xa, by contacting said derivatives with a composition containing...
|
|
|
7358239 |
Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
The present invention concerns compounds of formula (I)
a stereochemically isomeric form thereof, an N-oxide form thereof or a pharmaceutically acceptable acid addition salt thereof, wherein -Z...
|
|
|
7358269 |
2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronapthalen-1(2H)-one
A compound of the formula
or a pharmaceutically acceptable salt thereof, is disclosed herein. Methods and compositions related thereto are also disclosed.
|
|
|
7345072 |
Phenyltetrazole compounds
Novel phenyltetrazole compounds useful as intermediates in the preparation of angiotensin II antagonists and the processes for the conversion thereof to biologically active molecules.
|
|
|
7326696 |
Amino-methyl substituted tetracycline compounds
Aminomethyl substituted tetracycline compounds, pharmaceutical compositions, and methods of use thereof are discussed.
|
|
|
7323485 |
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
Compounds of Formula 1
where X is S and the variables have the meaning defined in the specification are specific or selective to alpha 2B and/or alpha 2C adrenergic receptors in...
|
|
|
7323433 |
R-(-)-1-[2-(7-chlorobenzo[b]thiopen-3-yl-methoxy)-2-(2,4-dichlorophenyl)-ethyl]-1H-imidazole
The invention relates to R-(−)-1-[2-(7-Chloro-benzo[b]thiophen-3-yl-methoxy)-2-(2,4
-dichloro-phenyl)-ethyl]-1H-imidazole and the salts thereof. The invention also relates to compositions thereof...
|
|
|
7317032 |
Imidazolyl inhibitors of 15-lipoxygenase
The present invention provides imidazolyl inhibitors of 15-LO, pharmaceutical compositions containing such inhibitors and methods for treating diseases related to the 15-LO cascade using such...
|
|
|
7288541 |
Propylcarbamate derivatives as inhibitors of serine and cysteine proteases
The present invention includes ketone derivatives (I) and (II), which are useful as cathepsin K inhibitors. The described invention also includes methods of making such ketone derivatives as well...
|